Xanthone: Benefits, Sources, and Side Effects

Xanthones are a class of plant-produced compounds that have drawn serious scientific interest for their antioxidant, anti-inflammatory, and antimicrobial properties. Most people encounter them through mangosteen, the tropical fruit whose thick purple rind is packed with dozens of xanthone variants, but these compounds also show up in certain lichens, fungi, and other plant families. Laboratory and early clinical research paints an intriguing picture of potential health benefits, though the gap between a promising cell-culture study and a proven therapy remains wide for most of those claims.

Where Xanthones Come From

Xanthones are secondary metabolites, meaning plants and fungi produce them not for basic growth but as chemical defenses or signaling molecules. In the plant kingdom, the majority are found in three families: Gentianaceae (gentians), Polygalaceae (milkworts), and Clusiaceae, the family that includes mangosteen.¹ Plants build their xanthone scaffolds through a pathway that starts with the shikimate pathway and runs through a benzophenone intermediate before an internal oxidative coupling reaction snaps the characteristic three-ring xanthone structure into place.² Fungi and lichens take a different route entirely, assembling the xanthone core from polyketide building blocks rather than from the amino-acid-derived pathway plants use.³

Mangosteen (Garcinia mangostana) is the most commercially relevant source. The edible white flesh inside contains relatively little xanthone; the real concentration is in the pericarp, the thick purple rind that most people throw away. Traditional medicine across Southeast Asia has long used that rind for abdominal pain, diarrhea, wound infections, and chronic ulcers.⁴ Today, dried pericarp extracts form the basis of most mangosteen-derived dietary supplements sold in the United States and Europe, marketed primarily as antioxidants.

Antioxidant Activity

The most frequently cited benefit of xanthones is their ability to neutralize free radicals, and the evidence for that specific activity is reasonably solid at the molecular level. Alpha-mangostin, the most abundant xanthone in mangosteen rind, acts as a free radical scavenger primarily through hydrogen atom transfer, the same basic mechanism by which many familiar antioxidants work.⁵ Computational and kinetic studies have found that alpha-mangostin’s scavenging capacity against peroxyl radicals is comparable to that of carotenoids and considerably stronger than that of melatonin or N-acetylcysteine amide.⁵ Extracts of the mangosteen fruit hull confirm that alpha-mangostin, along with epicatechin and tannins present in the same tissue, contribute to the overall antioxidant punch of the fruit.⁶

What “antioxidant” means in a test tube, though, does not automatically translate to meaningful antioxidant protection inside a living person. The body processes these compounds through its own metabolic machinery, and a large fraction gets chemically altered before it ever reaches the tissues where oxidative damage occurs. The antioxidant label is accurate for the chemistry but should not be mistaken for clinical proof that consuming xanthones prevents any specific disease.

Anti-Inflammatory Effects

Inflammation is where the laboratory evidence for xanthones looks particularly interesting. Both alpha-mangostin and beta-mangostin have been shown, in cell-culture studies, to selectively inhibit COX-2, the same enzyme targeted by drugs like celecoxib. Alpha-mangostin at a concentration of 14 micrograms per milliliter inhibited COX-2 activity by about 74% in stimulated cells and blocked the movement of the inflammatory signaling molecule NF-kB into the cell nucleus.⁷ Beta-mangostin showed a similar pattern, achieving about 53% COX-2 inhibition at 20 micrograms per milliliter while also suppressing NF-kB translocation.⁸

A separate line of research points to another anti-inflammatory mechanism: alpha-mangostin appears to activate SIRT-1, a protein involved in regulating inflammation and aging. When SIRT-1 was activated, the downstream inflammatory enzymes COX-2 and iNOS were turned down, and the production of inflammatory mediators like nitric oxide and prostaglandin E2 dropped. When researchers chemically blocked SIRT-1, those inflammatory markers came roaring back.⁹ This dual-pathway activity, hitting both the NF-kB route and the SIRT-1 route, is part of what makes xanthones stand out among plant-derived anti-inflammatory candidates. Still, these are cell and animal studies; no large human trial has confirmed that eating mangosteen or taking xanthone supplements meaningfully reduces chronic inflammation.

Anticancer Research in the Lab

Some of the most dramatic findings for xanthones involve cancer cells, but a strong caveat is warranted: virtually all of this work has been done in cell lines and animal models, not in human patients. Alpha-mangostin triggered programmed cell death in human colon cancer cells through both the internal (mitochondrial) and external (death receptor) pathways, increasing the expression of pro-death proteins like Bax and p53 while collapsing the mitochondrial membrane potential that cancer cells rely on.¹⁰ Similar results have been reported in breast cancer cells, including triple-negative and p53-mutant subtypes that are notoriously hard to treat with conventional therapies.¹¹

Oral squamous cell carcinoma cells showed the same vulnerability. Alpha-mangostin induced cell cycle arrest at the G1 phase, meaning cells got stuck before they could divide, and pushed them toward death through the mitochondrial pathway.¹² The consistency of these findings across multiple cancer types is noteworthy, but consistency in cell culture is not the same as proof of benefit in humans. Many compounds kill cancer cells in a dish yet fail in clinical trials because of poor absorption, toxicity, or insufficient concentrations at the tumor site. No xanthone has been approved as a cancer drug anywhere in the world.

Metabolic and Blood Sugar Effects

The metabolic angle is where xanthone research comes closest to actual human clinical data, though the evidence is still early. Gamma-mangostin, a less well-known xanthone sibling of alpha-mangostin, lowered blood sugar in diabetic mice over a 28-day period without signs of liver or kidney toxicity. It appeared to work by inhibiting the enzymes that break down starches into simple sugars and by enhancing insulin sensitivity in multiple cell types.¹³

A small randomized controlled pilot study in obese women provides the best human-level evidence so far. After 26 weeks of mangosteen extract supplementation, insulin levels dropped by roughly 53% in the treatment group compared to about 15% in the control group, and insulin resistance measured by HOMA-IR fell by about 51% versus 10%. These differences remained statistically significant even after adjusting for weight loss, though fasting glucose itself did not change meaningfully in either group.¹⁴ These numbers are encouraging but come from a single small trial in a specific population. They should not be generalized to all adults, and no one should replace diabetes medication with mangosteen supplements based on a pilot study.

Cardiovascular and Antimicrobial Properties

Xanthones have also been investigated for heart-protective effects. A review of their cardiovascular pharmacology found that the benefits likely stem from a combination of their antioxidant action, ability to inhibit platelet clumping, and blood-vessel-relaxing properties. One specific mechanism that stood out was their ability to counteract endogenous inhibitors of nitric oxide synthase, which could improve the function of blood vessel lining and potentially reduce plaque buildup associated with atherosclerosis.¹⁵ This work is largely theoretical and based on animal or cell models; no human cardiovascular outcome trials of xanthone supplementation exist.

On the antimicrobial front, xanthones have shown activity against some troublesome pathogens. A xanthone called calozeyloxanthone, isolated from Calophyllum tree species, demonstrated strong activity against methicillin-resistant Staphylococcus aureus (MRSA) at low concentrations.¹⁶ Researchers have also modified the alpha-mangostin molecule through synthetic chemistry to create analogs with even stronger antibacterial and antifungal activity than the original compound.¹⁷ With antibiotic resistance growing worldwide, plant-derived antimicrobial scaffolds like xanthones attract genuine interest from drug-development researchers, even though turning a promising molecule into a clinical antibiotic is an enormously difficult process.

Neuroprotection and Brain Health

Preclinical studies suggest that xanthone derivatives could protect brain cells through multiple routes: reducing oxidative stress, dampening neuroinflammation, and improving neurotransmitter signaling.¹⁸ A systematic review of xanthone effects on Alzheimer’s disease models found that these compounds promoted the survival of nerve cells, reduced the buildup of beta-amyloid plaques, and limited the clumping of tau protein, two of the hallmark pathological features of the disease.¹⁹ These are tantalizing results, but every piece of the evidence comes from animal models or cell lines. The leap from slowing plaque formation in a mouse brain to preventing or treating Alzheimer’s in a human is one of the hardest in all of biomedical research, and countless compounds that looked promising at this stage have failed later.

Skin Protection

Gamma-mangostin has been explored for anti-aging effects on skin, and the results from one recent study in both human skin cells and mice are worth noting. The compound inhibited collagenase and elastase, two enzymes that break down the structural proteins responsible for skin firmness, and it outperformed alpha-mangostin and beta-mangostin in these assays. In ultraviolet-B-exposed skin cells and mouse skin, gamma-mangostin reduced UV-induced oxidative damage, suppressed the production of matrix-degrading enzymes, and boosted the expression of collagen, elastin, and hyaluronic acid precursors. The compound appeared to achieve these effects partly by activating a cellular cleanup process called autophagy; when autophagy was blocked, the protective effects vanished.²⁰ This is interesting enough to explain why mangosteen extracts have started appearing in high-end skincare products, though the concentrations and formulations in commercial cosmetics may bear little relation to what was tested in the lab.

The Bioavailability Problem

All of those benefits share one major hurdle: xanthones are poorly absorbed by the human body. A study in healthy adults who drank mangosteen juice with a high-fat meal found that alpha-mangostin did reach the blood, but with enormous variation from person to person. Peak blood concentrations averaged around 113 nanomoles per liter but ranged wildly, and the total amount of xanthones recovered in 24-hour urine samples accounted for only about 2% of the ingested dose.²¹ The fat in the meal appeared to help absorption, which is consistent with xanthones being fat-soluble, but the overall picture is one of limited and inconsistent uptake.

Once absorbed, alpha-mangostin undergoes rapid modification by liver enzymes. Phase II metabolism converts much of it into glucuronidated and sulfated forms, which are generally less biologically active than the free compound.²² This matters because many of the dramatic cell-culture results were achieved by bathing cells directly in free alpha-mangostin at concentrations that may never be reached inside human tissue through oral supplementation. The extraction method used to produce supplements also affects what you actually get: different solvents and techniques pull out different amounts and ratios of xanthones, and the stability of the final product depends heavily on how the extraction was performed.²³

Drug Interactions and Side Effects

This is probably the most under-discussed aspect of xanthone supplementation. Mangosteen xanthones are both substrates and inhibitors of several cytochrome P450 enzymes, the same liver enzymes responsible for breaking down a wide range of prescription drugs. An in vitro study found that predicted blood concentrations of alpha-mangostin after ingestion would be well above the inhibitory thresholds for CYP2C8 and CYP2C9, two enzymes involved in metabolizing drugs like warfarin, certain diabetes medications, and nonsteroidal anti-inflammatory drugs.²⁴ Gartanin, another xanthone found in mangosteen, also showed inhibitory effects on CYP1A2 and altered the protein levels of CYP2C9 and CYP2D6 in liver cells.²⁵

What this means in practice: if you are taking any prescription medication metabolized through CYP2C8, CYP2C9, CYP1A2, or CYP2D6 pathways (and that covers a lot of commonly prescribed drugs), mangosteen supplements could potentially alter how fast your body clears those medications, leading to higher-than-expected drug levels or reduced effectiveness. This is not a theoretical concern; it mirrors the well-documented interaction between grapefruit juice and certain medications, though the specific enzymes involved differ somewhat. Anyone on prescription drugs should talk to a pharmacist or physician before adding mangosteen or xanthone supplements.

As for direct toxicity, the picture is more reassuring at typical supplement doses. Mangosteen pericarp extracts showed liver-protective effects in rats exposed to a chemical toxin, restoring liver enzyme levels and reducing cell damage at doses of 250 and 500 milligrams per kilogram of body weight.²⁶ There have been isolated case reports of liver injury associated with mangosteen-containing products, but these typically involve multi-ingredient supplements where causality is unclear. No systematic toxicity studies in large human populations have been published.

Supplements Versus Whole Fruit

The mangosteen supplement market is robust, with products ranging from freeze-dried pericarp capsules to juice blends that include the rind. But there is a meaningful difference between eating mangosteen fruit and taking a concentrated pericarp extract. The edible flesh of the fruit contains relatively small amounts of xanthones. The pericarp, where the xanthones are concentrated, is intensely bitter and not typically eaten. Supplement manufacturers extract and concentrate xanthones from the pericarp, but the resulting product can vary widely depending on extraction methods and quality control.

Research has catalogued the range of bioactivities that mangosteen xanthones can exhibit, including antibacterial, antifungal, anti-inflammatory, antioxidant, antiparasitic, and cell-killing properties, along with effects on specific enzymes like aromatase and topoisomerase.¹ The trouble is that having all those activities in a test tube does not mean a commercial supplement delivers them to your body in relevant amounts. With only about 2% of ingested xanthones showing up in urine after a meal, and with wide person-to-person variation in absorption, the dose you actually use biologically is a fraction of what is on the label. Newer extraction techniques, such as ultrasound-assisted extraction using deep eutectic solvents, have improved yields substantially (one method achieved about a 22% improvement over conventional extraction), but these advances primarily benefit researchers and manufacturers, not the end consumer trying to judge what they are getting in a capsule.²⁷

Beyond Mangosteen

While mangosteen dominates the conversation, it is not the only source of xanthones in nature. St. John’s wort (Hypericum perforatum) contains xanthones along with its better-known active compounds. Gentian root, used in digestive bitters across Europe for centuries, is another traditional source. Various Calophyllum species found in tropical forests yield xanthones with notable antimicrobial properties, as illustrated by the MRSA-active calozeyloxanthone.¹⁶ Fungi and lichens produce structurally distinct xanthones via a completely different biosynthetic pathway, which means the chemical diversity within the xanthone family is much broader than what you find in any single fruit.³ This diversity is relevant because different xanthone structures have different biological activities; the anticancer profile of alpha-mangostin, the skin-protective effects of gamma-mangostin, and the antimicrobial potency of calozeyloxanthone are all distinct properties carried by distinct molecular architectures within the same chemical family.

For researchers, this structural variety represents a large playground for drug design. Synthetic modification of natural xanthones has already produced analogs with enhanced antimicrobial properties, and the xanthone scaffold continues to attract attention as a template for developing new drugs targeting inflammation, infection, and cancer. Whether any of those efforts will produce an approved therapy remains an open question, but the chemical family itself has earned its place as one of the more interesting natural product groups under active investigation.